Ironwood Pharmaceuticals, Inc.(IRWD)
Biotechnology
Rare Disease / Orphan Drug
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-07-09 | Silver Ronald PFO & PAO | Sale | -127,890 | -50.62%124,746 | $4.52 | $578,063 | View SEC filing | |
| 2026-06-17 | McHugh Julie Director | Sale | -21,571 | -10.33%187,268 | $3.73 | $80,460 | View SEC filing | |
| 2026-03-17 | DENNER ALEXANDER J Director | Sale | -6,730,800 | -41.61%9,444,944 | $3.05 | $20,530,448 | View SEC filing | |
| 2026-02-25 | Martini Gregory S. Chief Financial Officer | Sale | -21,944 | -12.02%160,601 | $3.73 | $81,888 | View SEC filing | |
| 2026-02-25 | John Minardo Chief Legal Officer | Sale | -36,492 | -9.11%363,886 | $3.73 | $136,177 | View SEC filing | |
| 2026-02-25 | Shetzline Michael SVP, CMO, Head-Res&Drug | Sale | +1,442 | +0.14%1,059,862 | $3.73 | $121,586 | View SEC filing | |
| 2026-02-25 | Gaskins Tammi L Chief Commercial Officer | Sale | -21,526 | -9.15%213,738 | $3.73 | $80,328 | View SEC filing | |
| 2026-02-25 | MCCOURT Thomas A Chief Executive Officer | Sale | -198,283 | -11.75%1,489,002 | $3.73 | $739,929 | View SEC filing | |
| 2026-02-25 | Silver Ronald Principal Accounting Officer | Sale | -24,173 | -8.73%252,636 | $3.73 | $90,206 | View SEC filing | |
| 2026-01-07 | Silver Ronald Principal Accounting Officer | Sale | -35,416 | -11.34%276,809 | $4.60 | $162,914 | View SEC filing | |
| 2025-11-19 | Gaskins Tammi L Chief Commercial Officer | Sale | -6,016 | -2.49%235,264 | $3.32 | $19,973 | View SEC filing | |
| 2025-08-13 | Gaskins Tammi L Chief Commercial Officer | Sale | -1,316 | -0.54%241,280 | $0.84 | $1,105 | View SEC filing | |
| 2025-08-13 | John Minardo Chief Legal Officer | Sale | -7,754 | -1.90%400,378 | $0.84 | $6,513 | View SEC filing | |
| 2025-08-13 | Silver Ronald Principal Accounting Officer | Sale | -2,846 | -1.02%276,809 | $0.84 | $2,391 | View SEC filing | |
| 2025-08-13 | Martini Gregory S. Chief Financial Officer | Sale | -1,265 | -0.69%182,545 | $0.84 | $1,063 | View SEC filing | |
| 2025-05-20 | MCCOURT Thomas A Chief Executive Officer | Sale | -13,353 | -0.79%1,687,281 | $0.58 | $7,745 | View SEC filing | |
| 2025-05-20 | Gaskins Tammi L Chief Commercial Officer | Sale | -2,563 | -1.05%242,596 | $0.58 | $1,487 | View SEC filing | |
| 2025-02-12 | MCCOURT Thomas A Chief Executive Officer | Sale | -139,064 | -10.70%1,160,634 | $1.76 | $244,753 | View SEC filing | |
| 2025-02-12 | Silver Ronald Principal Accounting Officer | Sale | -12,048 | -4.13%279,655 | $1.76 | $21,204 | View SEC filing | |
| 2025-02-12 | Shetzline Michael SVP, CMO, Head-Res&Drug | Sale | -41,269 | -6.93%554,007 | $1.76 | $72,633 | View SEC filing | |
| 2025-02-12 | John Minardo Chief Legal Officer | Sale | -38,938 | -8.71%408,132 | $1.76 | $68,531 | View SEC filing | |
| 2025-02-12 | Martini Gregory S. Chief Financial Officer | Sale | -12,052 | -6.15%183,810 | $1.76 | $21,212 | View SEC filing | |
| 2024-11-20 | Davis Andrew SVP, Chief Business Officer | Sale | -5,360 | -1.85%284,685 | $4.08 | $21,869 | View SEC filing | |
| 2024-11-20 | Emany Sravan Kumar SVP, COO and CFO | Sale | -11,001 | -3.43%309,572 | $4.08 | $44,884 | View SEC filing | |
| 2024-08-14 | John Minardo Chief Legal Officer | Sale | -9,910 | -3.36%284,661 | $4.27 | $42,316 | View SEC filing |
1-25 of 267